Geptanolimab Antibody
Geptanolimab (CBT-501) is a humanized anti-PD-1 IgG4κ monoclonal antibody that reactivates T-cells by blocking PD-L1/2 interactions. It is being investigated in clinical trials for treating cancers such as peripheral T-cell lymphoma and has demonstrated activity in both preclinical in vitro and in vivo studies.
Product Specifications
Product Name Alternative
GB-226, Genolimzumab, APL501, APL-501, CBT501, CBT-501
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
5.18 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.14 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
